DexCom, Inc.

Company Details:

Company Symbol: DXCM
Sector: Healthcare & Medical Devices
Company Rating:
URL: http://www.dexcom.com/

Related Research

  • 04/27/17 Morning Note B. Riley AM Note: ACLS, AMAT, AVGO, AXTI, BRKS, CNK, DLB, DMRC, DXCM, HIBB, INTC, KLAC, LRCX, MRVL, OSIS, PRGX, RGC, ROG, SLAB, SONS, SUP, TYL, WMAR; Software (BLKB, CALD, CSOD, GUID, NTCT)
  • 04/27/17 Update DXCM ($75.68, Buy; $95.00 PT): Large Potential for “Therapeutic” CGMs Remains but Lowering 1Q:17 New User Growth due to a Competitive Overhang. Adjusting 2017 & 2018 Estimates and Maintaining Buy Rating and $95.00 Price Target.
  • 03/01/17 Morning Note B. Riley AM Note: ACLS, AMC, BV, DXCM, GPX, HSKA, LIOX (discontinuation), MCHP, NAME, OOMA, PRGX, RLH, SHOO, XOXO
  • 03/01/17 Update DXCM ($78.16, Buy; $95.00 PT): Another Top-Line Beat, Lower SG&A Leads to Narrower Loss Per Share, Increasing FY17 Revenue Estimates - Maintain Buy and Increasing Price Target to $95.00.
  • 02/13/17 Morning Note B. Riley AM Note: ADI, AMAT, AMC, CYTX, DXCM, FC, IMAX, SQNS; Internet (BCOV, GDDY, GRPN, TRUE)
  • 02/13/17 Update DXCM ($80.00, Buy; $94.00 PT): Our Survey Points to a Large Potential for “Therapeutic” CGMs. Adjusting 2017 Estimates and Raising Price Target to $94.00.
  • 01/06/17 Update Industry Update - MedTech: What Medical Technology Investors Should Know as the Healthcare Sector Descends on San Francisco on January 9-12, 2017
  • 12/15/16 Update DXCM ($64.14, Buy; $84.00 PT): Upgrading to Buy with $84 PT; Threat from Medtronic’s 670G May Turn Out to be Smaller Than Investors Think.
  • 12/15/16 Morning Note B. Riley AM Note: DXCM (upgrade), IEC, TLYS
  • 11/02/16 Update DXCM ($77.95, Neutral; $84.00 PT): Another Top-Line Beat, But Higher SG&A Expenses and Potential Competition Force Us to Reduce FY16 & FY17 Estimates - Maintain Neutral and Reducing Price Target to $84.00
  • 11/02/16 Morning Note B. Riley AM Note: ACLS, BLKB, CALD, CNK, DHX, DXCM, ELNK, GPX, HSKA, HZO, IPHI, IVAC, KEM, KTCC, KW, MBUU, OCLR, PRMW, RELY, RLH, RNWK, SANM, SHOO, TNAV, TNDM, TST, UEIC, VIAV
  • 09/27/16 Update Industry Update - Medical Technology: Positive Growth Trends Continue for the Diabetes Medical Technology Industry (DXCM, PODD, SENS, TNDM, VLRX)
  • 09/27/16 Initiation of Coverage DXCM ($93.16, Neutral; $97.00 PT): Very Strong Fundamentals, but a Rich Valuation Keep Us on the Sidelines; Initiating at Neutral with a $97.00 PT
  • 09/27/16 Morning Note B. Riley AM Note: HEAR, KE, P, Medical Technology Initiations (DXCM, PODD, SENS, TNDM, VLRX), Semiconductors (AVGO, ISIL, MCHP, MRVL, ON, SMTC, SWKS)